Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
419.50    0.50 (0.12%)
Bid:
420.00
Ask:
424.00
Spread: 4.00 (0.952%)
Market Cap: £145.71m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Director's Dealings

5 Sep 2018 16:26

RNS Number : 9036Z
Frontier Developments PLC
05 September 2018
 

5 September 2018

 

Frontier Developments plc

(the "Company")

 

Director's Dealings

 

The Company was notified on 5 September 2018 that David Gammon, Chairman of Frontier Developments plc, purchased 5,000 ordinary shares of 0.5p each in the Company ("Ordinary Shares") on behalf of his SIPP on 5 September 2018 at a price of 1045 pence per Ordinary Share.

 

Following this transaction, Mr Gammon, including direct family holdings, holds a total of 346,720 Ordinary Shares, representing 0.9 per cent of the Company's total issued share capital.

 

Enquiries:

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFO

 

 

Liberum - Nomad and Joint Broker

+44 (0)203 100 2000

Neil Patel /Cameron Duncan/William Hall

 

 

 

Finncap

+44 (0) 207 220 0500

Matt Goode/Giles Rolls

 

 

 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White/Matt Low

 

 

 

About Frontier Developments plc

Frontier Developments plc, listed on the AIM stock market (AIM: FDEV), is a leading independent creator of self-published video game franchises founded in 1994 by David Braben, co-author of the seminal Elite game. Based in Cambridge, Frontier uses its proprietary 'COBRA' game development technology to create innovative games, currently focusing on video game consoles and personal computers.

 

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

 

https://www.frontier.co.uk/ 

 

 

 

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated ("PCA")

a)

Name: David Gammon

2.

Reason for the notification

a)

Position/status: Chairman

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Purchase of Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

1045p

5000

 

d)

Aggregated information:

Volume - 5,000

Price - 1045p

e)

Date of the transactions: 5 September 2018

f)

Place of the transaction: London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEELFBVKFLBBQ
Date   Source Headline
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSLaunch of on-market Share Buyback Programme
26th Feb 20267:00 amRNSBlock Listing Return
11th Feb 202610:45 amRNSOption Grants / PDMR Dealings
27th Jan 20263:43 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSExcellent H1 Results & full year outlook upgraded
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
16th Dec 20257:00 amRNSCEO TRANSITION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.